Intravenous trimethoprim-sulfamethoxazole therapy for Pneumocystis carinii pneumonia

The American Journal of Medicine
F R Sattler, J S Remington


Twenty-nine immunocompromised patients were treated with intravenous trimethoprim-sulfamethoxazole for possible Pneumocystis carinii pneumonia. The diagnosis was established in 15 severely hypoxemic patients with lymphoreticular malignancy or cardiac transplants by open lung biopsy or transthoracic needle aspirate. In 13 (87 percent) of the 15, the response to therapy was rapid. They became afebrile in a mean of 2.1 days, showed improved arterial blood oxygenation in 4.7 days and improvements on the chest roentgenogram in 4.3 days. Eight (53 percent) of the 15 survived and were clinically cured. Five other patients with documented P. carinii infection improved clinically but subsequently died of other causes. Postmortem examination in these showed no P. carinii cysts. Two patients with P. carinii pneumonia died soon after therapy was started and had P. carinii cysts in lung tissue at autopsy. The combined clinical and microbiologic response of 87 percent equals or exceeds that of other reported treatment regimens. Intravenous trimethoprim-sulfamethoxazole may, therefore, be the most ideal therapy for severely ill adults with P. carinii pneumonia. Second lung biopsies in 12 patients on therapy showed that P. carinii cysts were r...Continue Reading


Jan 1, 1978·The American Journal of the Medical Sciences·D H Lawson, H Jick
Apr 1, 1978·Antimicrobial Agents and Chemotherapy·J E Bennett, A E Jennings
Dec 29, 1977·The New England Journal of Medicine·W T HughesS L George
Jun 1, 1975·The American Journal of Medicine·P P RosenD Armstrong
Sep 23, 1976·The New England Journal of Medicine·W K Lau, L S Young
Sep 23, 1976·The New England Journal of Medicine·W T Hughes
Jan 1, 1973·Medicine·B A Burke, R A Good
Nov 1, 1973·The Journal of Infectious Diseases·S R Bushby


Nov 1, 1987·Parasitology Today·W T Hughes
Dec 1, 1991·Mayo Clinic Proceedings·F R Cockerill, R S Edson
Feb 12, 1983·British Medical Journal·S B Kaye
Jun 1, 1985·Der Internist·A SzabadosF Deinhardt
Mar 1, 1984·The American Journal of Medicine·H W Haverkos
Mar 1, 1983·La Revue de médecine interne·C MayaudJ Roland
Jul 15, 1986·Cancer·J Skelton, P A Pizzo
Jan 1, 1997·Journal of Veterinary Internal Medicine·D C TwedtD M Getzy
Sep 1, 1986·American Journal of Hematology·B H BjornsonA I Tauber
Jan 1, 1984·Annals of the New York Academy of Sciences·A S TeirsteinW Talavera
Aug 1, 1985·Thorax·J T Macfarlane, R G Finch

Related Concepts

Needle Biopsy Procedure
Intravenous Injections
Pneumocystis Jiroveci Pneumonia

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.